+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030- Product Image
Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030- Product Image
Sale

Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • November 2024
  • Region: Global
  • 360iResearch™
  • ID: 6017226
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Febantel Market grew from USD 4.12 billion in 2023 to USD 4.29 billion in 2024. It is expected to continue growing at a CAGR of 4.96%, reaching USD 5.78 billion by 2030.

Febantel, a broad-spectrum anthelmintic, is widely utilized to treat and control parasitic infestations in animals, primarily in veterinary medicine for livestock and companion animals. The scope of its application encompasses treating infections caused by nematodes and other parasitic worms. The necessity for febantel arises from the growing incidence of parasitic infestations, which affect animal health, welfare, and productivity. Its efficacy in combination with other anthelmintics enhances its utility, providing comprehensive deworming solutions. This medication is crucial in the agricultural sector for enhancing livestock health and productivity, as well as in the pet industry to ensure animal wellness.

Market growth is influenced by factors like increasing pet ownership, advancements in veterinary medicine, and a rising awareness of animal health. The expansion of the agriculture and animal husbandry industries, especially in developing regions, significantly fuels demand. Moreover, the integration of febantel in combination therapies offers substantial growth prospects, catering to diverse parasitic challenges in various animals.

Potential opportunities include market expansion in emerging economies, where livestock farming is integral to the economy and improved distribution channels could enhance product availability. Recommendations include the development of more comprehensive deworming regimens and the exploration of febantel's role in sustainable agricultural practices.

However, market growth faces challenges such as regulatory complexities, potential resistance issues among parasitic species, and competition from alternative anthelmintics. Limitations in terms of awareness and access, particularly in less developed regions, further hinder market expansion. Innovations could focus on enhancing drug formulations to improve efficacy and safety, exploring febantel's potential in new therapeutic areas, and leveraging digital platforms to better educate stakeholders about its benefits. The market tends to be highly competitive and is characterized by ongoing research into improved formulations and delivery systems aimed at optimizing effectiveness while mitigating resistance and side effects, making continuous innovation and strategic market penetration vital for sustained growth.

Understanding Market Dynamics in the Febantel Market

The Febantel Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Technological advancements in the development of comprehensive, easy-to-administer anthelmintic solutions
    • Increased disposable incomes allowing pet owners to invest in premium care products, including dewormers
    • Rising prevalence of gastrointestinal parasites in livestock prompting a need for efficient treatments
  • Market Restraints
    • Exploring the consequences of supply chain disruptions affecting febantel distribution and production
    • How limited awareness about febantel among veterinarians and pet owners could hinder its market expansion
    • Addressing the public concerns over side effects which could adversely affect consumer confidence in febantel
  • Market Opportunities
    • Evaluating the potential of febantel in emerging pet care markets and trends
    • Enhancing febantel's market presence through innovative packaging and branding initiatives
    • Establishing febantel as a go-to solution in the equine veterinary care sector
  • Market Challenges
    • Managing competitive pressures from alternative parasiticide solutions and substitutes
    • Ensuring robust supply chain resilience to effectively respond to unforeseen disruptions
    • Addressing growing consumer demand for environmentally sustainable febantel products

Exploring Porter’s Five Forces for the Febantel Market

Porter’s Five Forces framework further strengthens the insights of the Febantel Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Febantel Market

External macro-environmental factors deeply influence the performance of the Febantel Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Febantel Market

The Febantel Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Febantel Market

The Febantel Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Febantel Market

The Febantel Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Febantel Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Bayer AG, Boehringer Ingelheim, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals, Elanco, Glenmark Pharmaceuticals, Huvepharma, Krka, d. d., Novo mesto, Kyoritsu Seiyaku, Meiji Seika Pharma, Merck Animal Health, Norbrook Laboratories, Phibro Animal Health, Sun Pharmaceutical Industries, Vetcare, Vetoquinol, Virbac, and Zoetis.

Market Segmentation & Coverage

This research report categorizes the Febantel Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Application
    • Antiparasitic Treatments
      • External Parasites
      • Intestinal Parasites
      • Lung Parasites
    • Veterinary Medicine
      • Cattle
        • Adult Cattle
        • Calves
      • Companion Animals
        • Cats
        • Dogs
      • Poultry
      • Swine
  • Industry Use
    • Animal Healthcare
      • Pharmaceutical Companies
      • Veterinary Clinics
    • Livestock Management
      • Animal Husbandry
      • Farming
  • Formulation Type
    • Liquid Formulations
      • Solutions
      • Suspensions
    • Solid Formulations
      • Powders
      • Tablets
  • Distribution Channel
    • Online Pharmacies
      • Direct to Consumer
      • Veterinary Specialized
    • Retail Pharmacies
    • Veterinary Pharmacies
  • End-User
    • Livestock Farmers
    • Pet Owners
    • Veterinarians
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  • Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  • Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  • Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  • Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  • Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  • What is the current size of the market, and how is it expected to grow?
  • Which products, segments, and regions present the most attractive investment opportunities?
  • What are the prevailing technology trends and regulatory factors influencing the market?
  • How do top vendors rank regarding market share and competitive positioning?
  • What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological advancements in the development of comprehensive, easy-to-administer anthelmintic solutions
5.1.1.2. Increased disposable incomes allowing pet owners to invest in premium care products, including dewormers
5.1.1.3. Rising prevalence of gastrointestinal parasites in livestock prompting a need for efficient treatments
5.1.2. Restraints
5.1.2.1. Exploring the consequences of supply chain disruptions affecting febantel distribution and production
5.1.2.2. How limited awareness about febantel among veterinarians and pet owners could hinder its market expansion
5.1.2.3. Addressing the public concerns over side effects which could adversely affect consumer confidence in febantel
5.1.3. Opportunities
5.1.3.1. Evaluating the potential of febantel in emerging pet care markets and trends
5.1.3.2. Enhancing febantel's market presence through innovative packaging and branding initiatives
5.1.3.3. Establishing febantel as a go-to solution in the equine veterinary care sector
5.1.4. Challenges
5.1.4.1. Managing competitive pressures from alternative parasiticide solutions and substitutes
5.1.4.2. Ensuring robust supply chain resilience to effectively respond to unforeseen disruptions
5.1.4.3. Addressing growing consumer demand for environmentally sustainable febantel products
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Febantel Market, by Application
6.1. Introduction
6.2. Antiparasitic Treatments
6.2.1. External Parasites
6.2.2. Intestinal Parasites
6.2.3. Lung Parasites
6.3. Veterinary Medicine
6.3.1. Cattle
6.3.1.1. Adult Cattle
6.3.1.2. Calves
6.3.2. Companion Animals
6.3.2.1. Cats
6.3.2.2. Dogs
6.3.3. Poultry
6.3.4. Swine
7. Febantel Market, by Industry Use
7.1. Introduction
7.2. Animal Healthcare
7.2.1. Pharmaceutical Companies
7.2.2. Veterinary Clinics
7.3. Livestock Management
7.3.1. Animal Husbandry
7.3.2. Farming
8. Febantel Market, by Formulation Type
8.1. Introduction
8.2. Liquid Formulations
8.2.1. Solutions
8.2.2. Suspensions
8.3. Solid Formulations
8.3.1. Powders
8.3.2. Tablets
9. Febantel Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.2.1. Direct to Consumer
9.2.2. Veterinary Specialized
9.3. Retail Pharmacies
9.4. Veterinary Pharmacies
10. Febantel Market, by End-User
10.1. Introduction
10.2. Livestock Farmers
10.3. Pet Owners
10.4. Veterinarians
11. Americas Febantel Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Febantel Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Febantel Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. FEBANTEL MARKET MULTI-CURRENCY
FIGURE 2. FEBANTEL MARKET MULTI-LANGUAGE
FIGURE 3. FEBANTEL MARKET RESEARCH PROCESS
FIGURE 4. FEBANTEL MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL FEBANTEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL FEBANTEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FEBANTEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FEBANTEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL FEBANTEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL FEBANTEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES FEBANTEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES FEBANTEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. FEBANTEL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. FEBANTEL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FEBANTEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FEBANTEL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FEBANTEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FEBANTEL MARKET DYNAMICS
TABLE 7. GLOBAL FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FEBANTEL MARKET SIZE, BY EXTERNAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FEBANTEL MARKET SIZE, BY INTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FEBANTEL MARKET SIZE, BY LUNG PARASITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FEBANTEL MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FEBANTEL MARKET SIZE, BY ADULT CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FEBANTEL MARKET SIZE, BY CALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FEBANTEL MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FEBANTEL MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FEBANTEL MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FEBANTEL MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FEBANTEL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FEBANTEL MARKET SIZE, BY ANIMAL HUSBANDRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FEBANTEL MARKET SIZE, BY FARMING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FEBANTEL MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FEBANTEL MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FEBANTEL MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FEBANTEL MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL FEBANTEL MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY SPECIALIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL FEBANTEL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL FEBANTEL MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL FEBANTEL MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL FEBANTEL MARKET SIZE, BY VETERINARIANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. CANADA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. CANADA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 99. CANADA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 100. CANADA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 101. CANADA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 102. CANADA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 103. CANADA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 104. CANADA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 105. CANADA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 107. CANADA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 108. CANADA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. CANADA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. CANADA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. MEXICO FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 119. MEXICO FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. MEXICO FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 124. MEXICO FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES FEBANTEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. CHINA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. CHINA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 171. CHINA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 172. CHINA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 173. CHINA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 174. CHINA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 175. CHINA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 176. CHINA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 177. CHINA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 178. CHINA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 179. CHINA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 180. CHINA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. CHINA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. CHINA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. INDIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. INDIA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 185. INDIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 186. INDIA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 187. INDIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 188. INDIA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 189. INDIA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 190. INDIA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 191. INDIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 192. INDIA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 193. INDIA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 194. INDIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. INDIA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. INDIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. JAPAN FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. JAPAN FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 213. JAPAN FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 214. JAPAN FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 215. JAPAN FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 216. JAPAN FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 217. JAPAN FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 218. JAPAN FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 219. JAPAN FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 220. JAPAN FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 221. JAPAN FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. JAPAN FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 224. JAPAN FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 285. TAIWAN FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 289. TAIWAN FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 290. TAIWAN FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 291. TAIWAN FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 292. TAIWAN FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. TAIWAN FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 294. TAIWAN FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. THAILAND FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. THAILAND FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 297. THAILAND FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 298. THAILAND FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 299. THAILAND FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 300. THAILAND FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 301. THAILAND FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 302. THAILAND FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 303. THAILAND FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 304. THAILAND FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 305. THAILAND FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 306. THAILAND FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. THAILAND FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. THAILAND FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. VIETNAM FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 322. VIETNAM FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA FEBANTEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 338. DENMARK FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 339. DENMARK FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 340. DENMARK FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 341. DENMARK FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 342. DENMARK FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 343. DENMARK FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 344. DENMARK FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 345. DENMARK FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 346. DENMARK FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 347. DENMARK FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 348. DENMARK FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 349. DENMARK FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. DENMARK FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 351. DENMARK FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 352. EGYPT FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. EGYPT FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 354. EGYPT FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 355. EGYPT FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 356. EGYPT FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 357. EGYPT FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 358. EGYPT FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 359. EGYPT FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 360. EGYPT FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 361. EGYPT FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 362. EGYPT FEBANTEL MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 363. EGYPT FEBANTEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 364. EGYPT FEBANTEL MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 365. EGYPT FEBANTEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 366. FINLAND FEBANTEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 367. FINLAND FEBANTEL MARKET SIZE, BY ANTIPARASITIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 368. FINLAND FEBANTEL MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 369. FINLAND FEBANTEL MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
TABLE 370. FINLAND FEBANTEL MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 371. FINLAND FEBANTEL MARKET SIZE, BY INDUSTRY USE, 2018-2030 (USD MILLION)
TABLE 372. FINLAND FEBANTEL MARKET SIZE, BY ANIMAL HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 373. FINLAND FEBANTEL MARKET SIZE, BY LIVESTOCK MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 374. FINLAND FEBANTEL MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 375. FINLAND FEBANTEL MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030

Companies Mentioned

  • Aurora Pharmaceutical
  • Bayer AG
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals
  • Elanco
  • Glenmark Pharmaceuticals
  • Huvepharma
  • Krka, d. d., Novo mesto
  • Kyoritsu Seiyaku
  • Meiji Seika Pharma
  • Merck Animal Health
  • Norbrook Laboratories
  • Phibro Animal Health
  • Sun Pharmaceutical Industries
  • Vetcare
  • Vetoquinol
  • Virbac
  • Zoetis

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.29 billion
Forecasted Market Value ( USD ) by 2030 $ 5.78 billion
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Febantel Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Febantel Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 123 Pages
  • Global
From
Febantel (CAS 58306-30-2) Global Market Research Report 2024 - Product Image

Febantel (CAS 58306-30-2) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Fenbendazole Market by Type, Disease Type, Sales Channel, Application, End User - Global Forecast 2025-2030 - Product Image

Fenbendazole Market by Type, Disease Type, Sales Channel, Application, End User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030 - Product Image

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From

About the Febantel Market

Febantel is a broad-spectrum anthelmintic used in veterinary medicine to treat parasitic worms in animals. It is a member of the benzimidazole family of drugs, which are used to treat a variety of parasitic infections. Febantel is used to treat roundworms, hookworms, whipworms, and tapeworms in dogs, cats, horses, and other animals. It is also used to treat gastrointestinal parasites in livestock, such as sheep, goats, and cattle. Febantel is available in a variety of formulations, including tablets, suspensions, and injectables. The Febantel market is a growing segment of the animal pharmaceuticals industry. It is driven by the increasing prevalence of parasitic infections in animals, as well as the need for effective treatments. The market is expected to continue to grow in the coming years, as new products are developed and new markets are explored. Some companies in the Febantel market include Merck Animal Health, Bayer Animal Health, Elanco Animal Health, Zoetis, and Virbac. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.